AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 24 filers reported holding AGILE THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $761,000 | -18.3% | 133,488 | 0.0% | 0.03% | -28.6% |
Q3 2016 | $932,000 | -8.3% | 133,488 | 0.0% | 0.04% | -20.8% |
Q2 2016 | $1,016,000 | +22.6% | 133,488 | 0.0% | 0.05% | -3.6% |
Q1 2016 | $829,000 | -36.4% | 133,488 | 0.0% | 0.06% | -33.7% |
Q4 2015 | $1,303,000 | +44.8% | 133,488 | 0.0% | 0.08% | +40.7% |
Q3 2015 | $900,000 | -21.5% | 133,488 | 0.0% | 0.06% | -1.7% |
Q2 2015 | $1,147,000 | -7.3% | 133,488 | 0.0% | 0.06% | +7.1% |
Q1 2015 | $1,237,000 | +54.2% | 133,488 | +2.2% | 0.06% | +43.6% |
Q4 2014 | $802,000 | +267.9% | 130,644 | +337.7% | 0.04% | +254.5% |
Q3 2014 | $218,000 | +14.1% | 29,850 | +36.0% | 0.01% | +22.2% |
Q2 2014 | $191,000 | – | 21,950 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ProQuest Associates IV LLC | 5,062,363 | $18,984,000 | 24.27% |
CAXTON CORP | 1,623,567 | $6,088,000 | 9.50% |
Vivo Capital, LLC | 1,513,975 | $5,677,000 | 1.43% |
Aisling Capital LLC | 1,804,933 | $6,768,000 | 1.16% |
INVESTOR AB | 3,510,189 | $13,163,000 | 0.92% |
Cormorant Asset Management, LP | 1,250,000 | $4,688,000 | 0.78% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 430,000 | $1,613,000 | 0.43% |
PURA VIDA INVESTMENTS, LLC | 174,501 | $654,000 | 0.26% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 955,109 | $3,582,000 | 0.19% |
ELEMENT CAPITAL MANAGEMENT LLC | 61,052 | $229,000 | 0.05% |